Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Artificial intelligence within the interplay between natural and artificial computation: Advances in data science, trends and applications
Indexado
WoS WOS:000579799300022
Scopus SCOPUS_ID:85086822378
DOI 10.1016/J.NEUCOM.2020.05.078
Año 2020
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Artificial intelligence and all its supporting tools, e.g. machine and deep learning in computational intelligence-based systems, are rebuilding our society (economy, education, life-style, etc.) and promising a new era for the social welfare state. In this paper we summarize recent advances in data science and artificial intelligence within the interplay between natural and artificial computation. A review of recent works published in the latter field and the state the art are summarized in a comprehensive and self-contained way to provide a baseline framework for the international community in artificial intelligence. Moreover, this paper aims to provide a complete analysis and some relevant discussions of the current trends and insights within several theoretical and application fields covered in the essay, from theoretical models in artificial intelligence and machine learning to the most prospective applications in robotics, neuroscience, brain computer interfaces, medicine and society, in general.

Revista



Revista ISSN
Neurocomputing 0925-2312

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Computer Science, Artificial Intelligence
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Górriz, Juan M. Hombre Universidad de Granada - España
University of Cambridge - Reino Unido
UNIV GRANADA - España
UNIV CAMBRIDGE - Reino Unido
2 Ramírez, Javier Hombre Universidad de Granada - España
UNIV GRANADA - España
3 Ortíz, Andrés Hombre Universidad de Málaga - España
Univ Malaga - España
4 Martínez-Murcia, Francisco J. Hombre Universidad de Málaga - España
Univ Malaga - España
5 Segovia, Fermin - Universidad de Granada - España
UNIV GRANADA - España
6 Suckling, John Hombre University of Cambridge - Reino Unido
UNIV CAMBRIDGE - Reino Unido
7 Leming, Matthew Hombre University of Cambridge - Reino Unido
UNIV CAMBRIDGE - Reino Unido
8 Zhang, Yu Dong - University of Leicester - Reino Unido
Univ Leicester - Reino Unido
9 Ramon Alvarez-Sanchez, Jose Hombre Univ Nacl Educ Distancia - España
Universidad Nacional de Educación a Distancia - España
9 Álvarez-Sánchez, Jose Ramón Hombre Universidad Nacional de Educación a Distancia - España
10 Bologna, Guido Hombre Université de Genève - Suiza
Univ Geneva - Suiza
11 Bonomini, Paula Mujer Universidad de Buenos Aires - Argentina
UNIV BUENOS AIRES - Argentina
12 Casado, Fernando E. Hombre Universidad de Santiago de Compostela - España
Univ Santiago de Compostela - España
13 Charte, David Hombre Universidad de Jaén - España
Univ Jaen - España
14 Charte, Francisco Hombre Universidad de Jaén - España
Univ Jaen - España
15 CONTRERAS-ARRIAGADA, RICARDO Hombre Universidad de Concepción - Chile
16 Cuesta-Infante, Alfredo Hombre Universidad Rey Juan Carlos - España
Univ Rey Juan Carlos - España
17 Duro, Richard J. Hombre Universidade da Coruña - España
Univ A Coruna - España
18 Fernández-Caballero, A. Hombre Universidad de Castilla-La Mancha - España
Univ Castilla La Mancha - España
19 Fernández-Jover, Eduardo Hombre Universidad Miguel Hernández de Elche - España
Univ Miguel Hernandez - España
20 Gómez-Vilda, Pedro Hombre Universidad Politécnica de Madrid - España
Univ Politecn Madrid - España
21 Grana, Manuel Hombre Universidad del País Vasco - España
Univ Basque Country - España
22 Herrera, Francisco Hombre Universidad de Granada - España
UNIV GRANADA - España
23 Iglesias, Roberto Hombre Universidad de Santiago de Compostela - España
Univ Santiago de Compostela - España
24 Lekova, Anna Mujer Bulgarian Academy of Sciences - Bulgaria
Bulgarian Acad Sci - Bulgaria
The Bulgarian Academy of Sciences - Bulgaria
25 de Lope, J. Hombre Universidad Politécnica de Madrid - España
Univ Politecn Madrid - España
26 López-Rubio, Ezequiel Hombre Universidad de Málaga - España
Univ Malaga - España
27 Martínez-Tomás, Rafael Hombre Universidad Nacional de Educación a Distancia - España
Univ Nacl Educ Distancia - España
28 Molina-Cabello, Miguel A. Hombre Universidad de Málaga - España
Univ Malaga - España
29 Montemayor, Antonio S. Hombre Universidad Rey Juan Carlos - España
Univ Rey Juan Carlos - España
30 Novais, Paulo Hombre Universidade do Minho - Portugal
Univ Minho - Portugal
31 Palacios-Alonso, Daniel Hombre Universidad Rey Juan Carlos - España
Univ Rey Juan Carlos - España
32 Pantrigo, Juan J. Hombre Universidad Rey Juan Carlos - España
Univ Rey Juan Carlos - España
33 Payne, Bryson R. Hombre University of North Georgia - Estados Unidos
Univ North Georgia - Estados Unidos
34 de la Paz López, Félix Hombre Universidad Nacional de Educación a Distancia - España
Univ Nacl Educ Distancia - España
35 Pinninghoff, María Angélica Mujer Universidad de Concepción - Chile
35 Angelica Pinninghoff, M. Mujer Universidad de Concepción - Chile
36 Rincón, Mariano Hombre Universidad Nacional de Educación a Distancia - España
Univ Nacl Educ Distancia - España
37 Santos, J. Hombre Universidade da Coruña - España
Univ A Coruna - España
38 Thurnhofer-Hemsi, Karl Hombre Universidad de Málaga - España
Univ Malaga - España
39 Tsanas, Athanasios Hombre The University of Edinburgh - Reino Unido
UNIV EDINBURGH - Reino Unido
40 Varela, Ramiro Hombre Universidad de Oviedo - España
Univ Oviedo - España
41 Ferrández, Jose M. Hombre Universidad Politécnica de Cartagena - España
Univ Politecn Cartagena - España

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
National Natural Science Foundation of China
National Institutes of Health
Spanish Ministry of Science
Medical Research Council
Pfizer Inc.
Canadian Institutes of Health Research
Alzheimer's Association
Ministerio de Ciencia e Innovación
Royal Society
Bristol-Myers Squibb
University of California, San Diego
Engineering and Physical Sciences Research Council
British Council
Servier
Lundbeck
Eisai
Comunidad de Madrid
Michael J. Fox Foundation for Parkinson's Research
National Institute on Aging
Abbott Laboratories
Merck Co., Inc.
AbbVie
U.S. Department of Defense
Pfizer
Eli Lilly and Company
Genentech
Mauritius Research Council
University of Southern California
FPU Program
Abbott
Juan de la Cierva
Alzheimer’s Association
Merck & Co
Roche
GE Healthcare
Biogen
National Institute of Biomedical Imaging and Bioengineering
Euroimmun
H. Lundbeck A/S
Takeda Pharmaceutical Company
Bristol-Myers Squibb Company
Biogen Idec
Novartis Pharmaceuticals Corporation
Eisai Inc.
BioClinica, Inc.
Lumosity
Piramal Imaging
Neurotrack Technologies
Elan Pharmaceuticals, Inc.
IXICO Ltd.
CereSpir, Inc.
NeuroRx Research
Transition Therapeutics
Alzheimer's Drug Discovery Foundation
Janssen Alzheimer Immunotherapy Research & Development, LLC.
Fujirebio
Araclon Biotech
DOD ADNI
BioClinica
Johnson & Johnson Pharmaceutical Research & Development LLC.
Meso Scale Diagnostics, LLC.
Alzheimer's Disease Neuroimaging Initiative
Johnson and Johnson Pharmaceutical Research and Development
DoD Alzheimer's Disease Neuroimaging Initiative
F. Hoffman-La Roche Ltd.
Conselleria de Cultura, Educacion e Ordenacion Universitaria of Galicia
Autonomous Government of Andalusia (Spain)
DOD ADNI (Department of Defense)
F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)
Fujirebio Europe
Janssen Alzheimer Immunotherapy Research AMP; Development, LLC.
Johnson AMP; Johnson Pharmaceutical Research AMP; Development LLC.
Janssen Alzheimer Immunotherapy Research And Development
Northern California Institute for Research and Education
Ordenaci?n Universitaria of Galicia

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The work reported here has been partially funded by many public and private bodies. Spanish Ministry of Science, projects: TIN2017-85827-P, RTI2018-098913-B-I00, PSI2015-65848-R, PGC2018-098813-B-C31, PGC2018-098813-B-C32, RTI2018-101114-B-I, TIN2017-90135-R, RTI2018-098743-B-I00 and RTI2018-094645-B-I00; the FPU program (FPU15/06512, FPU17/04154) and Juan de la Cierva (FJCI-2017?33022). Autonomous Government of Andalusia (Spain) projects: UMA18-FEDERJA-084. Conseller?a de Cultura, Educaci?n e Ordenaci?n Universitaria of Galicia: ED431C2017/12, accreditation 2016?2019, ED431G/08, ED431C2018/29, Comunidad de Madrid, Y2018/EMT-5062 and grant ED431F2018/02. PPMI ? a public ? private partnership ? is funded by The Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbott, Biogen Idec, F. Hoffman-La Roche Ltd. GE Healthcare, Genentech and Pfizer Inc. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.;Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co. Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
PPMI – a public – private partnership – is funded by The Michael J. Fox Foundation for Parkinson’s Research and funding partners, including Abbott, Biogen Idec, F. Hoffman-La Roche Ltd., GE Healthcare, Genentech and Pfizer Inc.
Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.;Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.
Prof. Yu-Dong Zhang received his BE in 2004, and MPhil in 2007, from Nanjing University of Aeronautics and Astronautics. He received the PhD degree from Southeast University in 2010. He worked as a postdoc from 2010 to 2012 with Columbia University, USA; and as an assistant research scientist from 2012 to 2013 with Research Foundation of Mental Hygiene (RFMH), USA. He served as a full professor from 2013 to 2017 with Nanjing Normal University. Now he serves as Professor with Department of Informatics, University of Leicester, UK. Prof. Zhang is the fellow of IET (FIET). He was included in “Most Cited Chinese researchers (Computer Science)” by Elsevier from 2014 to 2018. He was the 2019 recipient of “Highly Cited Researcher” by Web of Science. He has conducted many successful industrial projects and academic grants from NSFC, NIH, Royal Society, EPSRC, MRC, and British Council.
The work reported here has been partially funded by many public and private bodies. Spanish Ministry of Science, projects: TIN2017-85827-P, RTI2018-098913-B-I00, PSI2015-65848-R, PGC2018-098813-B-C31, PGC2018-098813-B-C32, RTI2018-101114-B-I, TIN2017-90135-R, RTI2018-098743-B-I00 and RTI2018-094645-B-I00; the FPU program (FPU15/06512, FPU17/04154) and Juan de la Cierva (FJCI-2017-33022). Autonomous Government of Andalusia (Spain) projects: UMA18-FEDERJA-084. Conselleria de Cultura, Educacion e Ordenacion Universitaria of Galicia: ED431C2017/12, accreditation 2016-2019, ED431G/08, ED431C2018/29, Comunidad de Madrid, Y2018/EMT-5062 and grant ED431F2018/02.r PPMI - a public - private partnership - is funded by The Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbott, Biogen Idec, F. Hoffman-La Roche Ltd., GE Healthcare, Genentech and Pfizer Inc.r Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.;Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.

Muestra la fuente de financiamiento declarada en la publicación.